期刊
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
卷 85, 期 1, 页码 187-199出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2020.09.039
关键词
acute pain; chronic pain; hidradenitis suppurativa; neuropathic; nociceptive; pain management; treatment
类别
资金
- National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002378, KL2TR002381]
- Building Interdisciplinary Research Careers in Women's Health of the National Institutes of Health [K12D085850]
While specific data for HS pain management is lacking, categorizing HS pain as acute or chronic, nociceptive or neuropathic provides a framework for applying external pain management practices to HS treatment.
Pain contributes substantially to reduced quality of life in individuals living with hidradenitis suppurativa (HS). Although improved understanding of HS pathogenesis and treatment has resulted in improved evidence-based HS management guidelines, comprehensive pain management guidelines have yet to be developed. Few HS-specific data exist to guide pharmacologic analgesia; however, recognizing HS pain as either acute or chronic and predominantly nociceptive (aching and gnawing pain due to tissue damage) versus neuropathic (burning-type pain due to somatosensory nervous system dysfunction) provides a conceptual framework for applying outside pain management practices to HS management. This article incorporates the best available evidence from the HS and pain literature to propose an HS pain algorithm that integrates psychological, pharmacologic, and complementary and alternative treatment modalities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据